Genetic Variants of IgG1 Antibodies and FcγRIIIa Receptors Influence the Magnitude of Antibody-Dependent Cell-Mediated Cytotoxicity Against Prostate Cancer Cells
OncoImmunology- United States
doi 10.4161/onci.27317
Full Text
Abstract
Available in
Date
January 1, 2014
Authors
Publisher
Informa UK Limited